when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Novo Nordisk Inc · news · pharmadog

← back to Novo Nordisk Inc

News mentioning Novo Nordisk Inc

167 stories

Jul 20, 26STAT+: Pharmalittle: We’re reading about a telehealth firm and patient safety, PBMs overcharging, and morestat

Jul 20, 26HHS vaccine committee quietly gets new charterstat

Jul 20, 26STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputerstat

Jul 20, 26STAT+: Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers saystat

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 17, 26Compounders maintain a firm grip on the GLP-1 marketbiopharma dive

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 15, 26STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and morestat

Jul 14, 26Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pillbiopharma dive

Jul 14, 26STAT+: Akero team, backed by Fairmount, launches new immunology companystat

Jul 14, 26Former Akero team announces new I&I company, Avere, with China drugendpoints

Jul 10, 26The data that led Cellular Intelligence to pick up Novo's Parkinson's stem cell therapyendpoints

Jul 9, 26Catalent to divest UK site; Rottendorf, Evonik announce manufacturing buildsendpoints

Jul 9, 26Opinion: Who benefits from classifying obesity as a disease?stat

Jul 7, 26Kailera says obesity pill succeeds in late-stage trial in Chinabiopharma dive

Jul 2, 26STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and morestat

Jul 2, 26The new presidential fitness test is a positive step, not the solution, experts saystat

Jul 1, 26STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenesstat

Jun 30, 26Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from Congressstat

Jun 30, 26Half of states sue over Medicaid work requirementsstat

Jun 30, 26STAT+: Even with MAHA, Trump administration has gone soft on alcoholstat

Jun 30, 26STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordiskstat

Jun 29, 265 takeaways from STAT’s investigation into microhospital operator Nutex Healthstat

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 20, 26Biopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and moreendpoints

Jun 18, 26Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50Mendpoints

Jun 18, 26STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and morestat

Jun 18, 26What’s next for GLP-1 weight loss drugs?stat

Jun 17, 26UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy saysendpoints

Jun 17, 26Hackers claim they stole Novo Nordisk AI models, manufacturing recipesendpoints

← prevpage 4 of 6next →